Association of Anti-cyclic Citrullinated Peptide Antibodies with Clinical and Radiological Disease Severity in Rheumatoid Arthritis

By  

Current Rheumatology Reviews, Vol. 10, Iss. 2, 2014-09 ,pp. : 136-143

Bentham Science Publishers

Access to resources Recommend Favorite

Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis

By Grootenboer-Mignot S   Nicaise-Roland P   Delaunay C   Meyer O   Chollet-Martin S   Labarre C  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 218-220

Informa Healthcare

Access to resources Recommend Favorite

Anti-cyclic citrullinated peptide antibodies do not reflect self-reported disability and physical health in patients with rheumatoid arthritis of less than 5 years of duration

By Poulsen Chalotte   Jacobsen Søren   Frisch Morten   Frederiksen Kirsten   Johansen Christoffer  

Rheumatology International, Vol. 33, Iss. 11, 2013-11 ,pp. : 2763-2772

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis

By Emad Yasser   Shehata Mohamed   Ragab Yasser   Saad Ahmed   Hamza Hosny   Abou-Zeid Alaa  

Modern Rheumatology, Vol. 20, Iss. 4, 2010-08 ,pp. : 358-365

Springer Publishing Company

Access to resources Recommend Favorite

Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis

By Brunner Jürgen K.H.   Sitzmann Friedrich C.  

Modern Rheumatology, Vol. 16, Iss. 6, 2006-12 ,pp. : 372-375

Springer Publishing Company

Access to resources Recommend Favorite